Skip to main content
SpringerLink
Log in

Biological Therapy for Rheumatoid Arthritis

  • Chapter
  • First Online:
Gerontorheumatology

  • 720 Accesses

Abstract

Rheumatoid arthritis (RA) is one of the most severe and most frequent inflammatory rheumatic diseases, which may develop at any age.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bathon JM, Fleischmann RM, van der Heijde DM, et al. Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis. J Rheumatol. 2006;33(2):234–42.

    CAS  PubMed  Google Scholar 

  2. Bresnihan B, Alvaro-Garcia JM, Cobby M, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998;41:2196–3004.

    Article  CAS  PubMed  Google Scholar 

  3. Filippini M, Bazzani C, Zingarelli S, et al. Anti-TNF-alpha agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients. Reumatismo. 2008;60(1):41–9.

    CAS  PubMed  Google Scholar 

  4. Fleischmann R, Baumgartner SW, Weisman MH, et al. Long term safety of etanercept in elderly subjects with rheumatic diseases. Ann Rheum Dis. 2006;65:379–478.

    Article  CAS  PubMed  Google Scholar 

  5. Koller MD, Aletaha D, Funovits J, et al. Response of elderly patients with rheumatoid arthritis to methotrexate and TNF inhibitors compared with younger patients. Rheumatology. 2009;48:1575–80.

    Article  PubMed  Google Scholar 

  6. Migliore A, Bizzi E, Lagana B, et al. The safety of anti-TNF agents in the elderly. Int J Immunopathol Pharmacol. 2009;22(2):415–26.

    Article  CAS  PubMed  Google Scholar 

  7. Ogasawara M, Tamura N, Onuma S, et al. Observational cross-sectional study revealing less aggressive treatment in japanese elderly than nonelderly patients with rheumatoid arthritis. J Clin Rheumatol. 2010;16(8):370–4.

    Article  PubMed  Google Scholar 

  8. Onishi S, Iwmoto M, Minota S. Management of elderly-onset rheumatoid arthritis. Jpn J Clin Immunol. 2010;33(1):1–7.

    Article  Google Scholar 

  9. Tutuncu Z, Reed G, Kremer J, et al. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis. 2006;65:1226–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Villa-Blanco JI, Calvo-Alen J. Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy. Drugs Aging. 2009;26(9):739–50.

    Article  CAS  PubMed  Google Scholar 

  11. Wolfe F, Michaud K. Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med. 2004;116:305–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute of Rheumatic Diseases, Piešťany, Slovakia

    Jozef Rovenský, Dagmar Mičeková & Vanda Mlynáriková

Authors
  1. Jozef Rovenský
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dagmar Mičeková
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vanda Mlynáriková
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jozef Rovenský .

Editor information

Editors and Affiliations

  1. National Institute of Rheumatic Diseases, Piešťany, Slovakia

    Jozef Rovenský

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rovenský, J., Mičeková, D., Mlynáriková, V. (2017). Biological Therapy for Rheumatoid Arthritis. In: Rovenský, J. (eds) Gerontorheumatology. Springer, Cham. https://doi.org/10.1007/978-3-319-31169-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-31169-2_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-31167-8

  • Online ISBN: 978-3-319-31169-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation